Title | Type | SJR | H index | Total Docs. (2007) | Total Docs. (3years) | Total Refs. (2007) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2007) | %Female (2007) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
48 | Iranian Journal of Pharmacology and Therapeutics | journal | 0.101 Q4 | 24 | 39 | 31 | 1121 | 2 | 31 | 0.06 | 28.74 | 28.85 | |
47 | Ankara Universitesi Eczacilik Fakultesi Dergisi | journal | 0.102 Q4 | 13 | 15 | 62 | 395 | 5 | 62 | 0.00 | 26.33 | 67.57 | |
46 | Journal of Pharmacy of Istanbul University | journal | 0.102 Q4 | 11 | 14 | 11 | 169 | 0 | 11 | 0.00 | 12.07 | 68.75 | |
45 | Turkish Journal of Pharmaceutical Sciences | journal | 0.112 Q4 | 22 | 15 | 15 | 365 | 2 | 15 | 0.13 | 24.33 | 39.68 | |
44 | Journal of Medicinal Plants | journal | 0.118 Q4 | 27 | 53 | 125 | 1155 | 9 | 125 | 0.06 | 21.79 | 26.45 | |
43 | Fabad Journal of Pharmaceutical Sciences | journal | 0.120 Q4 | 19 | 24 | 89 | 877 | 11 | 85 | 0.10 | 36.54 | 49.28 | |
42 | Iranian Journal of Medical Sciences | journal | 0.127 | 40 | 60 | 168 | 1163 | 18 | 154 | 0.10 | 19.38 | 19.08 | |
41 | Acta Pharmaceutica Sciencia | journal | 0.144 Q3 | 23 | 25 | 69 | 578 | 9 | 68 | 0.02 | 23.12 | 40.00 | |
40 | Reviews on Recent Clinical Trials | journal | 0.150 Q4 | 35 | 28 | 31 | 2317 | 7 | 30 | 0.23 | 82.75 | 28.57 | |
39 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.204 Q3 | 17 | 38 | 39 | 4108 | 8 | 34 | 0.21 | 108.11 | 39.39 | |
38 | Current Computer-Aided Drug Design | journal | 0.210 Q4 | 32 | 24 | 28 | 2269 | 16 | 26 | 0.57 | 94.54 | 36.23 | |
37 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.211 Q3 | 27 | 35 | 141 | 3958 | 60 | 126 | 0.40 | 113.09 | 39.13 | |
36 | Current Drug Safety | journal | 0.218 Q3 | 41 | 30 | 33 | 1789 | 23 | 33 | 0.70 | 59.63 | 33.33 | |
35 | Current Enzyme Inhibition | journal | 0.245 Q3 | 19 | 25 | 29 | 3343 | 22 | 29 | 0.76 | 133.72 | 38.46 | |
34 | Letters in Drug Design and Discovery | journal | 0.261 Q2 | 37 | 99 | 213 | 3076 | 129 | 213 | 0.61 | 31.07 | 33.33 | |
33 | Current Clinical Pharmacology | journal | 0.389 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
32 | Recent Patents on CNS Drug Discovery | journal | 0.398 Q3 | 36 | 22 | 25 | 2775 | 29 | 25 | 1.16 | 126.14 | 29.63 | |
31 | Current Pharmaceutical Analysis | journal | 0.435 Q2 | 27 | 28 | 32 | 2492 | 32 | 32 | 1.00 | 89.00 | 31.87 | |
30 | Anti-Infective Agents | journal | 0.457 Q3 | 26 | 24 | 75 | 2422 | 83 | 69 | 0.92 | 100.92 | 18.18 | |
29 | Current Neuropharmacology | journal | 0.489 Q3 | 103 | 27 | 83 | 3824 | 86 | 79 | 0.94 | 141.63 | 21.15 | |
28 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.499 Q3 | 52 | 22 | 27 | 2750 | 35 | 27 | 1.30 | 125.00 | 42.19 | |
27 | Current Drug Discovery Technologies | journal | 0.557 Q2 | 49 | 27 | 68 | 1603 | 134 | 67 | 1.52 | 59.37 | 25.33 | |
26 | Medicinal Chemistry | journal | 0.576 Q2 | 50 | 73 | 133 | 2773 | 215 | 133 | 1.62 | 37.99 | 30.65 | |
25 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.716 Q2 | 43 | 35 | 100 | 3696 | 233 | 100 | 2.16 | 105.60 | 35.71 | |
24 | Combinatorial Chemistry and High Throughput Screening | journal | 0.784 Q2 | 70 | 86 | 250 | 5158 | 650 | 230 | 2.46 | 59.98 | 25.46 | |
23 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.866 Q2 | 45 | 32 | 115 | 3098 | 306 | 108 | 2.62 | 96.81 | 35.11 | |
22 | Current Nanoscience | journal | 0.958 Q1 | 52 | 39 | 35 | 2293 | 81 | 33 | 2.31 | 58.79 | 22.81 | |
21 | Current Drug Delivery | journal | 0.959 Q1 | 72 | 35 | 129 | 2110 | 425 | 127 | 3.24 | 60.29 | 29.32 | |
20 | Mini-Reviews in Medicinal Chemistry | journal | 1.113 Q1 | 107 | 114 | 339 | 11701 | 1183 | 322 | 3.32 | 102.64 | 28.78 | |
19 | Infectious Disorders - Drug Targets | journal | 1.158 Q1 | 61 | 35 | 89 | 3848 | 270 | 83 | 2.97 | 109.94 | 29.17 | |
18 | Current Vascular Pharmacology | journal | 1.362 Q1 | 69 | 33 | 116 | 3168 | 482 | 111 | 4.51 | 96.00 | 16.67 | |
17 | Current Drug Targets | journal | 1.433 Q1 | 119 | 137 | 323 | 15626 | 1350 | 290 | 4.19 | 114.06 | 28.77 | |
16 | Current Gene Therapy | journal | 1.447 Q1 | 80 | 42 | 144 | 4712 | 670 | 139 | 4.93 | 112.19 | 27.05 | |
15 | Current Pharmaceutical Design | journal | 1.781 Q1 | 183 | 337 | 1056 | 38981 | 5047 | 939 | 4.98 | 115.67 | 30.67 | |
14 | Current Topics in Medicinal Chemistry | journal | 1.782 Q1 | 133 | 190 | 419 | 13804 | 1817 | 360 | 4.28 | 72.65 | 25.43 | |
13 | Current Medicinal Chemistry | journal | 1.834 Q1 | 202 | 261 | 652 | 36052 | 3639 | 630 | 5.26 | 138.13 | 31.32 | |
12 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.839 Q1 | 108 | 52 | 143 | 7350 | 751 | 137 | 5.98 | 141.35 | 28.57 | |
11 | CNS and Neurological Disorders - Drug Targets | journal | 2.059 Q1 | 96 | 45 | 162 | 6068 | 794 | 147 | 4.47 | 134.84 | 28.72 | |
10 | Current Cancer Drug Targets | journal | 2.814 Q1 | 103 | 79 | 146 | 9022 | 840 | 143 | 5.77 | 114.20 | 30.65 | |
9 | Current Bioactive Compounds | journal | 31 | 17 | 0 | 1782 | 0 | 0 | 0.00 | 104.82 | 32.56 | ||
8 | Current Drug Therapy | journal | 20 | 30 | 0 | 2159 | 0 | 0 | 0.00 | 71.97 | 20.00 | ||
7 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 23 | 28 | 2501 | 21 | 28 | 0.75 | 108.74 | 29.31 | ||
6 | Drug Metabolism Letters | journal | 31 | 53 | 0 | 136 | 0 | 0 | 0.00 | 2.57 | 29.39 | ||
5 | Iranian Journal of Basic Medical Sciences | journal | 57 | 16 | 0 | 414 | 0 | 0 | 0.00 | 25.88 | 23.91 | ||
4 | Iranian Journal of Pharmaceutical Research | journal | 58 | 46 | 125 | 1048 | 27 | 114 | 0.15 | 22.78 | 25.98 | ||
3 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 22 | 30 | 2265 | 26 | 30 | 0.87 | 102.95 | 20.83 | ||
2 | Recent Advances in Drug Delivery and Formulation | journal | 41 | 22 | 0 | 1672 | 0 | 0 | 0.00 | 76.00 | 19.67 | ||
1 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 28 | 0 | 2149 | 0 | 0 | 0.00 | 76.75 | 35.29 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®